Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence

doi:10.5409/wjcp.v5.i2.212

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13626)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

1317

WORD

291

HTML

8633

Figures (1-3)

247

Tables (1-2)

270

Sum=10758

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1246

Download

1622

Sum=2868

May 8, 2016 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Pediatr. May 8, 2016; 5(2): 212-222
Published online May 8, 2016. doi: 10.5409/wjcp.v5.i2.212

Full Size Figure Download Figure

Figure 2 Outcomes of the Cochrane review comparing dopamine vs dobutamine in preterm infants.

Citation: Bhayat SI, Gowda HMS, Eisenhut M. Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence. World J Clin Pediatr 2016; 5(2): 212-222
URL: https://www.wjgnet.com/2219-2808/full/v5/i2/212.htm
DOI: https://dx.doi.org/10.5409/wjcp.v5.i2.212